Is Biktarvy covered by insurance?

Most commercial and government health insurance plans in the U.S. cover some portion of the cost for Biktarvy. Typically a person taking Biktarvy pays between $0 and $5 per month. A co-pay card program for Biktarvy offers up to $7,200 in cost-sharing assistance per year with no monthly limit.

Your cost will depend on your insurance plan, prescription benefit coverage, and any deductibles or copays you may have. You may be able to access financial assistance through Gilead, the manufacturer of this drug.

Biktarvy (bictegravir, emtricitabine, and tenofovir) is approved as an oral, once-daily complete HIV treatment regimen. It is used in adults and children who weight at least 14 kg (31 lbs):

• who have not taken HIV-1 medicine in the past, or
• to replace their current HIV-1 medicine if they are virologically suppressed (HIV-1 RNA less than 50 copies per mL), on a stable antiretroviral regimen with no known or suspected substitutions associated with resistance to bictegravir or tenofovir.

Commercial insurance: If you have commercial, private or employer-sponsored coverage, Gilead offers the Advancing Access co-pay card program. The co-pay card program offers up to $7,200 in cost-sharing assistance per calendar year with no monthly limit. You will typically pay between $0 and $5 per month. Call your insurance carrier to determine if Biktarvy is covered on your plan.

Patients enrolled in Medicare Part D and Medicaid, including patients in the Medicare Part D coverage gap ("donut hole”), Medigap, DOD, and VA/Tricare enrollees are not eligible for the Gilead copay coupon.

Medicare / Medicaid / Other government programs: Typically a person with Medicare or Medicaid will pay between $0 and $9 per month. Copays can differ between states.

Financial assistance for people with government-sponsored insurance is also available through non-profit co-pay foundations. They may be able to support out-of-pocket (OOP) costs including copays, coinsurance, or deductibles.

No insurance: Gilead Sciences also offers the Gilead Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP) to help you afford your medicine. Gilead may be able to assist you if you are insured, underinsured, or have no insurance. If eligible, You may be able to receive the medication free of charge.

Gilead also offers support to you and your physician if your Biktarvy prescription coverage is denied by your insurance plan or you require Prior Authorization or an appeal.

You can sign up for these programs online, or for more information, contact Gilead Sciences at:

• GileadAdvancingAccess.com or
• call ‍‍1-800-226-2056 M–F, 9am–8pm ET

If you are not able to enroll in the Gilead Advancing Access programs online, speak to your healthcare provider who has access to the program online and can help you sign up.

This is not all the information you need to know about Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) for safe and effective use and does not take the place of your healthcare providers directions. Discuss this information and any questions you have with your doctor or other health care provider.

Related questions

• Which medicines should not be taken with Biktarvy?
• Can Biktarvy be used for PrEP or PEP?
• What if I miss a dose of Biktarvy?